1 min read

Chad Conner and Patrick Eckstrom of Mycrodose Therapeutics

Chad Conner and Patrick Eckstrom of Mycrodose Therapeutics

Mycrodose Therapeutics is a US-Based pharmaceutical company specializing in the development of Advanced Drug Delivery (ADD) systems for psychedelic compounds.

On this episode of The Integration Conversation, Mycrodose's Chad Conner and Patrick Eckstrom join Brom to discuss how ADD systems can potentially improve the patient experience, increase the safety profile and lower the cost of psychedelic drugs.